Alibaba Health Information Technology Limited (ALBBY)

Market Cap	6.28B -46.8%
Revenue (ttm)	4.97B +12.0%
Net Income	280.71M +35.2%
EPS	0.35 +34.6%
Shares Out	n/a
PE Ratio	21.88
Forward PE	19.05
Dividend	0.57 (7.55%)
Ex-Dividend Date	Aug 13, 2026

Volume	1,144
Open	7.49
Previous Close	7.70
Day's Range	7.49 - 7.64
52-Week Range	6.59 - 17.52
Beta	1.52
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 25, 2026

About ALBBY

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People’s Republic of China. It offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, healthcare food, adult and family planning products, and various other health-related products. The company also provides medical and healthcare services, including medical checkups, testing...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1998
• Employees: 1,394
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALBBY

Financial Performance

In fiscal year 2026, ALBBY's revenue was 34.26 billion, an increase of 11.95% compared to the previous year's 30.60 billion. Earnings were 1.94 billion, an increase of 35.17%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 9, 2026

Data Sources Report a data error